News

Why Novo Nordisk Stock Eked Out a Win on Monday
According to the article, that investor aims to influence the company's choice of a chief executive.
Activist hedge fund Parvus builds stake in Novo Nordisk, FT reports
Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk , after the company lost its first mover ...
Notable healthcare headlines for the week: Bristol Myers Squibb, Novo Nordisk and Sanofi in focus
Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.
Zacks Investment Research on MSN3d
Is Novo Nordisk's Next Generation Obesity Pipeline a Game Changer?
Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide ...
$2B Novo Nordisk deal shakes up pharma market
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
Novo Nordisk's Ozempic Has Rare Vision-Loss Side Effect, EU Regulator Says
The European Medicines Agency said an eye condition that might cause loss of vision is a very rare side effect of Novo Nordisk's blockbuster drugs Ozempic and Wegovy.